Adial Pharmaceuticals Inc (ADIL)
1.71
+0.01
(+0.59%)
USD |
NASDAQ |
Apr 24, 16:00
1.71
0.00 (0.00%)
After-Hours: 06:40
Adial Pharmaceuticals Cash from Operations (TTM): -6.807M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.807M |
September 30, 2023 | -7.335M |
June 30, 2023 | -9.348M |
March 31, 2023 | -10.99M |
December 31, 2022 | -11.19M |
September 30, 2022 | -11.81M |
June 30, 2022 | -11.93M |
March 31, 2022 | -11.60M |
December 31, 2021 | -11.95M |
September 30, 2021 | -12.19M |
June 30, 2021 | -10.87M |
March 31, 2021 | -8.651M |
December 31, 2020 | -7.633M |
Date | Value |
---|---|
September 30, 2020 | -6.772M |
June 30, 2020 | -6.288M |
March 31, 2020 | -6.443M |
December 31, 2019 | -6.339M |
September 30, 2019 | -5.690M |
June 30, 2019 | -4.956M |
March 31, 2019 | -4.005M |
December 31, 2018 | -2.498M |
September 30, 2018 | -1.517M |
June 30, 2018 | -0.6621M |
March 31, 2018 | -0.6238M |
December 31, 2017 | -0.4949M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-12.19M
Minimum
Sep 2021
-4.956M
Maximum
Jun 2019
-8.884M
Average
-8.651M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
BioVie Inc | -41.11M |
BioSig Technologies Inc | -17.31M |
Precision BioSciences Inc | -84.11M |
Humacyte Inc | -73.30M |
Monogram Orthopaedics Inc | -13.54M |